[Relationship between cardiac natriuretic peptide (ANP/BNP) and fluid intake in patients with subarachnoid

K Fukui1, T Inamura, A Nakamizo

  • 1Department of Neurosurgery, Graduate School of Medical Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

No to Shinkei = Brain and Nerve
|February 24, 2001
PubMed

Insights

Fluid intake significantly influences natriuretic peptide levels, specifically brain natriuretic peptide (BNP), in subarachnoid hemorrhage (SAH) patients. This finding suggests iatrogenic factors may contribute to natriuresis post-SAH.

Area of Science:

  • Neurosurgery
  • Endocrinology
  • Cardiology

Background:

  • Subarachnoid hemorrhage (SAH) is associated with altered fluid and electrolyte balance.
  • Elevated natriuretic peptides, atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), are frequently observed in SAH patients.
  • These peptide elevations have been linked to the syndromes of inappropriate antidiuretic hormone (SIADH) or cerebral salt wasting (CSW).

Observation:

  • The role of fluid intake volume in natriuretic peptide secretion post-SAH has been previously overlooked.
  • This study investigated the relationship between fluid intake and natriuretic peptides in two non-cardiac failure SAH cases.
  • Atrial natriuretic peptide (ANP) showed a delayed elevation post-SAH, normalizing within two weeks.

Findings:

  • Brain natriuretic peptide (BNP) levels correlated directly with increased fluid intake volumes.
  • BNP levels remained unchanged during periods of restricted fluid intake.
  • These observations support the hypothesis that iatrogenic factors may influence natriuresis following SAH.

Implications:

  • Fluid management strategies in SAH patients may need to consider their impact on natriuretic peptide levels.
  • Understanding the interplay between fluid intake and natriuretic peptides can refine the diagnosis and management of SIADH and CSW in SAH.
  • Further research is warranted to elucidate the precise mechanisms and clinical significance of fluid-induced natriuretic peptide changes in SAH.

Related Concept Videos

Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...